These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 22204713

  • 1. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J, Gill AJ, Issacs JD, Atmore B, Johns A, Delbridge LW, Lai R, McMullen TP.
    Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
    [Abstract] [Full Text] [Related]

  • 2. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
    Lantsov D, Meirmanov S, Nakashima M, Kondo H, Saenko V, Naruke Y, Namba H, Ito M, Abrosimov A, Lushnikov E, Sekine I, Yamashita Sh.
    Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
    [Abstract] [Full Text] [Related]

  • 3. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
    Ji XK, Xie YK, Zhong JQ, Xu QG, Zeng QQ, Wang Y, Zhang QY, Shan YF.
    Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
    [Abstract] [Full Text] [Related]

  • 4. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
    Lee SH, Lee JK, Jin SM, Lee KC, Sohn JH, Chae SW, Kim DH.
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
    He F, Li H, Li WS, Dong XH.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 17; 89(6):393-6. PubMed ID: 19567117
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.
    Khoo ML, Beasley NJ, Ezzat S, Freeman JL, Asa SL.
    J Clin Endocrinol Metab; 2002 Apr 17; 87(4):1814-8. PubMed ID: 11932323
    [Abstract] [Full Text] [Related]

  • 8. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
    Cho YJ, Yoon J, Ko YS, Kim SY, Cho SJ, Kim WH, Park JW, Youn HD, Kim JH, Lee BL.
    APMIS; 2010 Oct 17; 118(10):782-90. PubMed ID: 20854473
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
    Sun J, Yan P, Chen Y, Chen Y, Yang J, Xu G, Mao H, Qiu Y.
    Diagn Pathol; 2015 Jun 19; 10():72. PubMed ID: 26088648
    [Abstract] [Full Text] [Related]

  • 10. Biological and clinical significance of GSK-3beta in mantle cell lymphoma--an immunohistochemical study.
    Chung R, Peters AC, Armanious H, Anand M, Gelebart P, Lai R.
    Int J Clin Exp Pathol; 2010 Jan 25; 3(3):244-53. PubMed ID: 20224723
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ, Chua MS, Wei W, So SK.
    Oncotarget; 2015 Oct 06; 6(30):29847-59. PubMed ID: 26359353
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of beta-catenin, phosphorylated glycogen synthase kinase 3beta, cyclin D1, and c-myc in laterally spreading colorectal tumors.
    Wang J, Wang X, Gong W, Mi B, Liu S, Jiang B.
    J Histochem Cytochem; 2009 Apr 06; 57(4):363-71. PubMed ID: 19064714
    [Abstract] [Full Text] [Related]

  • 14. Cyclin D1, Ret and P27 Expression in Papillary Thyroid Microcarcinoma.
    Barić A, Marković V, Eterović D, Bedeković V, Kontić M, Juretić Kuščić L, Pešutić Pisac V, Punda A.
    Acta Clin Croat; 2017 Mar 06; 56(1):15-20. PubMed ID: 29120119
    [Abstract] [Full Text] [Related]

  • 15. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
    Takahashi-Yanaga F, Yoshihara T, Jingushi K, Igawa K, Tomooka K, Watanabe Y, Morimoto S, Nakatsu Y, Tsuzuki T, Nakabeppu Y, Sasaguri T.
    Biochem Pharmacol; 2014 Jun 01; 89(3):340-8. PubMed ID: 24670930
    [Abstract] [Full Text] [Related]

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G, Li Y, Yoshimoto K, Wu Q, Chen G, Iwata T, Mizusawa N, Wan C, Nie X.
    Toxicol Lett; 2014 Jan 30; 224(3):362-70. PubMed ID: 24231000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM.
    Ann Surg Oncol; 2007 Dec 30; 14(12):3403-11. PubMed ID: 17882495
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y, Liu Z, Zhang X, He J, Pan Y, Hao F, Xie L, Li Q, Qiu X, Wang E.
    Cancer Lett; 2013 Aug 09; 336(1):231-9. PubMed ID: 23673211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.